Advertisement

Computational Investigation on Electrostatic Loop Mutants Instigating Destabilization and Aggregation on Human SOD1 Protein Causing Amyotrophic Lateral Sclerosis

  • E. Srinivasan
  • R. RajasekaranEmail author
Article

Abstract

Mutations in the gene encoding Cu/Zn Superoxide Dismutase 1 (SOD1) protein are contemplated to be a protruding reason for Amyotrophic lateral sclerosis (ALS), which leads towards protein aggregation, misfolding and destabilization. Thus, we investigated the systematic action of entire mutations reported on electrostatic loop of SOD1 protein through thermodynamical and discrete molecular dynamics (DMD) studies. Accordingly, we analyzed the outcomes distinctly for screening the mutant structures having both, deleterious and destabilizing effect. Progressively, the impacts of those mutations on SOD1 were studied using DMD program. Surprisingly, our results predicted that the mutants viz., L126S, N139H and G141A to be the most destabilizing, misfolded and disease-causing compared to other mutants. Besides, the outcomes from secondary structural propensities and free energy landscapes, together assertively suggested that L126S, N139H and G141A tend to increase the formation of aggregates in SOD1 relative to other mutants. Hence, this study could provide an insight into the sprouting neurodegenerative disorder distressing the humans.

Keywords

SOD1 ALS Aggregation Electrostatic loop Destabilizing DMD 

Notes

Acknowledgements

The authors thank the management of VIT (deemed to be University) for providing the VIT-SEED GRANT, facilities and encouragement to carry out this research work.

Compliance with Ethical Standards

Conflict of interest

The authors declare that there are no conflicts of interest.

References

  1. 1.
    Kumar S, Nussinov R (2002) Close-range electrostatic interactions in proteins. ChemBioChem 3:604–617.  https://doi.org/10.1002/1439-7633(20020703)3:7%3C604::AID-CBIC604%3E3.0.CO;2-X.Google Scholar
  2. 2.
    Zhou H-X, Pang X (2018) Electrostatic interactions in protein structure, folding, binding, and condensation. Chem Rev 118:1691–1741.  https://doi.org/10.1021/acs.chemrev.7b00305 Google Scholar
  3. 3.
    Nakamura H (1996) Roles of electrostatic interaction in proteins. Q Rev Biophys 29:1–90.  https://doi.org/10.1017/S0033583500005746 Google Scholar
  4. 4.
    Tan W, Pasinelli P, Trotti D (2014) Role of mitochondria in mutant SOD1 linked amyotrophic lateral sclerosis. Biochim Biophys Acta 1842:1295–1301.  https://doi.org/10.1016/j.bbadis.2014.02.009 Google Scholar
  5. 5.
    Karch CM, Borchelt DR (2008) A limited role for disulfide cross-linking in the aggregation of mutant SOD1 linked to familial amyotrophic lateral sclerosis. J Biol Chem 283:13528–13537.  https://doi.org/10.1074/jbc.M800564200 Google Scholar
  6. 6.
    Kunishige M, Hill KA, Riemer AM, Farwell KD, Halangoda A, Heinmöller E, Moore SR, Turner DM, Sommer SS (2001) Mutation frequency is reduced in the cerebellum of Big Blue® mice overexpressing a human wild type SOD1 gene. Mutat Res 473:139–149.  https://doi.org/10.1016/S0027-5107(00)00120-2 Google Scholar
  7. 7.
    Osredkar J (2011) Copper and zinc, biological role and significance of copper/zinc imbalance. J Clin Toxicol.  https://doi.org/10.4172/2161-0495.S3-001 Google Scholar
  8. 8.
    Radunović A, Leigh PN (1996) Cu/Zn superoxide dismutase gene mutations in amyotrophic lateral sclerosis: correlation between genotype and clinical features. J Neurol Neurosurg Psychiatry 61:565–572.  https://doi.org/10.1136/jnnp.61.6.565 Google Scholar
  9. 9.
    Valentine JS, Doucette PA, Zittin Potter S (2005) Copper-zinc superoxide dismutase and amyotrophic lateral sclerosis. Annu Rev Biochem 74:563–593.  https://doi.org/10.1146/annurev.biochem.72.121801.161647 Google Scholar
  10. 10.
    Furukawa Y, O’halloran TV (2006) Posttranslational modifications in Cu, Zn-superoxide dismutase and mutations associated with amyotrophic lateral sclerosis. Antioxid Redox Signal 8:847–867.  https://doi.org/10.1089/ars.2006.8.847 Google Scholar
  11. 11.
    Galaleldeen A, Strange RW, Whitson LJ, Antonyuk SV, Narayana N, Taylor AB, Schuermann JP, Holloway SP, Hasnain SS, Hart PJ (2009) Structural and biophysical properties of metal-free pathogenic SOD1 mutants A4V and G93A. Arch Biochem Biophys 492:40–47.  https://doi.org/10.1016/j.abb.2009.09.020 Google Scholar
  12. 12.
    Rakhit R, Chakrabartty A (2006) Structure, folding, and misfolding of Cu, Zn superoxide dismutase in amyotrophic lateral sclerosis. Biochim Biophys Acta 1762:1025–1037.  https://doi.org/10.1016/j.bbadis.2006.05.004 Google Scholar
  13. 13.
    Srinivasan E, Sethumadhavan R, Rajasekaran R (2017) A theoretical study on Zn binding loop mutants instigating destabilization and metal binding loss in human SOD1 protein. J Mol Model 23:103.  https://doi.org/10.1007/s00894-017-3286-z Google Scholar
  14. 14.
    Srinivasan E, Rajasekaran R (2017) Computational simulation analysis on human SOD1 mutant (H80R) exposes the structural destabilization and the deviation of Zn binding that directs familial amyotrophic lateral sclerosis. J Biomol Struct Dyn 35:2645–2653.  https://doi.org/10.1080/07391102.2016.1227723 Google Scholar
  15. 15.
    Srinivasan E, Rajasekaran R (2018) Deciphering the loss of metal binding due to mutation D83G of human SOD1 protein causing FALS disease. Int J Biol Macromol 107:521–529.  https://doi.org/10.1016/j.ijbiomac.2017.09.019 Google Scholar
  16. 16.
    Srinivasan E, Rajasekaran R (2017) Exploring the cause of aggregation and reduced Zn binding affinity by G85R mutation in SOD1 rendering amyotrophic lateral sclerosis. Proteins 85:1276–1286.  https://doi.org/10.1002/prot.25288 Google Scholar
  17. 17.
    Getzoff ED, Cabelli DE, Fisher CL, Parge HE, Viezzoli MS, Banci L, Hallewell RA (1992) Faster superoxide dismutase mutants designed by enhancing electrostatic guidance. Nature 358:347–351.  https://doi.org/10.1038/358347a0 Google Scholar
  18. 18.
    Polticelli F, Bottaro G, Battistoni A, Carrì MT, Djinovic-Carugo K, Bolognesi M, O’Neill P, Rotilio G, Desideri A (1995) Modulation of the catalytic rate of Cu, Zn superoxide dismutase in single and double mutants of conserved positively and negatively charged residues. Biochemistry 34:6043–6049Google Scholar
  19. 19.
    Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O’Regan JP, Deng HX (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362:59–62.  https://doi.org/10.1038/362059a0 Google Scholar
  20. 20.
    Culotta VC, Yang M, O’Halloran TV (2006) Activation of superoxide dismutases: putting the metal to the pedal. Biochim Biophys Acta 1763:747–758.  https://doi.org/10.1016/j.bbamcr.2006.05.003 Google Scholar
  21. 21.
    Rotunno MS, Bosco DA (2013) An emerging role for misfolded wild-type SOD1 in sporadic ALS pathogenesis. Front Cell Neurosci.  https://doi.org/10.3389/fncel.2013.00253 Google Scholar
  22. 22.
    Healy EF, Cervantes L (2016) An in silico study of the effect of SOD1 electrostatic loop dynamics on amyloid-like filament formation. Eur Biophys J 45:853–859.  https://doi.org/10.1007/s00249-016-1163-9 Google Scholar
  23. 23.
    Keerthana SP, Kolandaivel P (2015) Structural investigation on the electrostatic loop of native and mutated SOD1 and their interaction with therapeutic compounds. RSC Adv 5:34630–34644.  https://doi.org/10.1039/c5ra00286a Google Scholar
  24. 24.
    Ciriolo MR, Battistoni A, Falconi M, Filomeni G, Rotilio G (2001) Role of the electrostatic loop of Cu, Zn superoxide dismutase in the copper uptake process. Eur J Biochem 268:737–742.  https://doi.org/10.1046/j.1432-1327.2001.01928.x Google Scholar
  25. 25.
    Elam JS, Taylor AB, Strange R, Antonyuk S, Doucette PA, Rodriguez JA, Hasnain SS, Hayward LJ, Valentine JS, Yeates TO, Hart PJ (2003) Amyloid-like filaments and water-filled nanotubes formed by SOD1 mutant proteins linked to familial ALS. Nat Struct Biol 10:461–467.  https://doi.org/10.1038/nsb935 Google Scholar
  26. 26.
    Wroe R, Wai-Ling Butler A, Andersen PM, Powell JF, Al-Chalabi A (2008) ALSOD: the amyotrophic lateral sclerosis online database. Amyotroph Lateral Scler 9:249–250.  https://doi.org/10.1080/17482960802146106 Google Scholar
  27. 27.
    Apweiler R, Bairoch A, Wu CH, Barker WC, Boeckmann B, Ferro S, Gasteiger E, Huang H, Lopez R, Magrane M, Martin MJ (2004) UniProt: the universal protein knowledgebase. Nucleic Acids Res 32:D115–D119.  https://doi.org/10.1093/nar/gkh131 Google Scholar
  28. 28.
    Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE (2000) The protein data bank. Nucleic Acids Res 28:235–242Google Scholar
  29. 29.
    Kaplan W, Littlejohn TG (2001) Swiss-PDB viewer (deep view). Brief Bioinform 2:195–197.  https://doi.org/10.1093/bib/2.2.195 Google Scholar
  30. 30.
    Darden T, York D, Pedersen L (1993) Particle mesh Ewald: an N⋅log (N) method for Ewald sums in large systems. J Chem Phys 98:10089.  https://doi.org/10.1063/1.464397 Google Scholar
  31. 31.
    Bendl J, Stourac J, Salanda O, Pavelka A, Wieben ED, Zendulka J, Brezovsky J, Damborsky J (2014) PredictSNP: robust and accurate consensus classifier for prediction of disease-related mutations. PLoS Comput Biol 10:e1003440.  https://doi.org/10.1371/journal.pcbi.1003440 Google Scholar
  32. 32.
    Rodrigues CHM, Pires DEV, Ascher DB (2018) DynaMut: predicting the impact of mutations on protein conformation, flexibility and stability. Nucleic Acids Res 46:W350–W355.  https://doi.org/10.1093/nar/gky300 Google Scholar
  33. 33.
    Dokholyan NV, Buldyrev SV, Stanley HE, Shakhnovich EI (1998) Discrete molecular dynamics studies of the folding of a protein-like model. Fold Des 3:577–587.  https://doi.org/10.1016/S1359-0278(98)00072-8 Google Scholar
  34. 34.
    Shirvanyants D, Ding F, Tsao D, Ramachandran S, Dokholyan NV (2012) Discrete molecular dynamics: an efficient and versatile simulation method for fine protein characterization. J Phys Chem B 116:8375–8382.  https://doi.org/10.1021/jp2114576 Google Scholar
  35. 35.
    Lazaridis T, Karplus M (1999) Effective energy function for proteins in solution. Proteins 35:133–152Google Scholar
  36. 36.
    Ding F, Tsao D, Nie H, Dokholyan NV (2008) Ab initio folding of proteins with all-atom discrete molecular dynamics. Structure 16:1010–1018.  https://doi.org/10.1016/j.str.2008.03.013 Google Scholar
  37. 37.
    Andersen HC (1980) Molecular dynamics simulations at constant pressure and/or temperature. J Chem Phys 72:2384–2393.  https://doi.org/10.1063/1.439486 Google Scholar
  38. 38.
    Ding F, Dokholyan NV (2008) Dynamical roles of metal ions and the disulfide bond in Cu, Zn superoxide dismutase folding and aggregation. Proc Natl Acad Sci USA 105:19696–19701.  https://doi.org/10.1073/pnas.0803266105 Google Scholar
  39. 39.
    McCammon JA (1984) Protein dynamics. Rep Prog Phys 47:1.  https://doi.org/10.1088/0034-4885/47/1/001 Google Scholar
  40. 40.
    Papaleo E, Mereghetti P, Fantucci P, Grandori R, De Gioia L (2009) Free-energy landscape, principal component analysis, and structural clustering to identify representative conformations from molecular dynamics simulations: the myoglobin case. J Mol Graph Model 27:889–899.  https://doi.org/10.1016/j.jmgm.2009.01.006 Google Scholar
  41. 41.
    Likic V, Gooley PR, Speed TP, Strehler EE (2005) UBER VIP P value A statistical approach to the interpretation of molecular dynamics simulations of calmodulin equilibrium dynamics. Protein Sci 14:2955–2963.  https://doi.org/10.1110/ps.051681605 Google Scholar
  42. 42.
    Teng S, Wang L, Srivastava AK, Schwartz CE, Alexov E (2010) Structural assessment of the effects of amino acid substitutions on protein stability and protein-protein interaction. Int J Comput Biol Drug Des 3:334–349.  https://doi.org/10.1504/IJCBDD.2010.038396 Google Scholar
  43. 43.
    Reva B, Antipin Y, Sander C (2011) Predicting the functional impact of protein mutations: application to cancer genomics. Nucleic Acids Res 39:e118.  https://doi.org/10.1093/nar/gkr407 Google Scholar
  44. 44.
    Tokuriki N, Tawfik DS (2009) Stability effects of mutations and protein evolvability. Curr Opin Struct Biol 19:596–604.  https://doi.org/10.1016/j.sbi.2009.08.003 Google Scholar
  45. 45.
    Beckerman M (2015) Fundamentals of neurodegeneration and protein misfolding disorders. Springer, New YorkGoogle Scholar
  46. 46.
    Ye L, Wu Z, Eleftheriou M, Zhou R (2007) Single-mutation-induced stability loss in protein lysozyme. Biochem Soc Trans 35:1551–1557.  https://doi.org/10.1042/BST0351551 Google Scholar
  47. 47.
    Cerdà-Costa N, Esteras-Chopo A, Avilés FX, Serrano L, Villegas V (2007) Early kinetics of amyloid fibril formation reveals conformational reorganisation of initial aggregates. J Mol Biol 366:1351–1363.  https://doi.org/10.1016/j.jmb.2006.12.007 Google Scholar
  48. 48.
    Dong M, Li H, Hu D, Zhao W, Zhu X, Ai H (2016) Molecular dynamics study on the inhibition mechanisms of drugs CQ1–3 for Alzheimer amyloid-β40 aggregation induced by Cu2+. ACS Chem Neurosci.  https://doi.org/10.1021/acschemneuro.5b00343 Google Scholar
  49. 49.
    Khandogin J, Brooks CL (2007) Linking folding with aggregation in Alzheimer’s β-amyloid peptides. Proc Natl Acad Sci USA 104:16880–16885.  https://doi.org/10.1073/pnas.0703832104 Google Scholar
  50. 50.
    Gross M (2000) Proteins that convert from alpha helix to beta sheet: implications for folding and disease. Curr Protein Pept Sci 1:339–347.  https://doi.org/10.2174/1389203003381289 Google Scholar
  51. 51.
    Meiering EM (2008) The threat of instability: neurodegeneration predicted by protein destabilization and aggregation propensity. PLoS Biol 6:1383–1385.  https://doi.org/10.1371/journal.pbio.0060193 Google Scholar
  52. 52.
    Stevens JC, Chia R, Hendriks WT, Bros-Facer V, Van Minnen J, Martin JE, Jackson GS, Greensmith L, Schiavo G, Fisher EMC (2010) Modification of superoxide dismutase 1 (SOD1) properties by a GFP tag—implications for research into amyotrophic lateral sclerosis (ALS). PLoS ONE 5:e9541.  https://doi.org/10.1371/journal.pone.0009541 Google Scholar
  53. 53.
    Srinivasan E, Rajasekaran R (2018) Cysteine to serine conversion at 111th position renders the disaggregation and retains the stabilization of detrimental SOD1 A4V mutant against amyotrophic lateral sclerosis in human—a discrete molecular dynamics study. Cell Biochem Biophys 76:231–241.  https://doi.org/10.1007/s12013-017-0830-5 Google Scholar
  54. 54.
    Srinivasan E, Rajasekaran R (2017) Probing the inhibitory activity of epigallocatechin-gallate on toxic aggregates of mutant (L84F) SOD1 protein through geometry based sampling and steered molecular dynamics. J Mol Graph Model 74:288–295.  https://doi.org/10.1016/j.jmgm.2017.04.019 Google Scholar
  55. 55.
    Srinivasan E, Rajasekaran R (2016) Computational investigation of curcumin, a natural polyphenol that inhibits the destabilization and the aggregation of human SOD1 mutant (Ala4Val). RSC Adv 6:102744–102753.  https://doi.org/10.1039/c6ra21927f Google Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Bioinformatics Lab, Department of Biotechnology, School of Bio Sciences and TechnologyVIT (Deemed to be University)VelloreIndia

Personalised recommendations